Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Menopause cost-effectiveness of therapy
Introduction
Overview
Overview
Given the morbidity associated with menopause, and the high cost of HRT and non- hormonal therapy, current pharmacotherapy to treat menopause are cost-effective.
Cost-Effectiveness of Therapy
Cost-Effectiveness of Therapy
- Hormone replacement therapy is cost-effective for the relief of menopausal symptoms either was severe or mild.
- HRT is not cost-effective for asymptomatic women for prevention of medical diseases associated with postmenopause.
- The Cost-effectiveness of hormone replacement therapy ratios between 10,000 – a million $ per QALY (quality-adjusted life expectancy).
- There are several factors that improved cost-effectiveness such as the long duration of therapy, the presence of menopausal symptoms, and minimum side effects of hormonal therapy.
- Non-hormonal therapy such as SNRIs and SSRIs are relatively cost-effectiveness for relief of menopausal symptoms.[1][2][3][4]
References
References
- ↑ Lekander I, Borgström F, Ström O, Zethraeus N, Kanis JA (2009). “Cost-effectiveness of hormone therapy in the United States”. J Womens Health (Larchmt). 18 (10): 1669–77. doi:10.1089/jwh.2008.1246. PMID 19857096.
- ↑ Burger H (2003). “Hormone replacement therapy in the post-Women’s Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003”. Climacteric. 6 Suppl 1: 11–36. PMID 12945798.
- ↑ Cheung AP, Wren BG (1992). “A cost-effectiveness analysis of hormone replacement therapy in the menopause”. Med J Aust. 156 (5): 312–6. PMID 1588862.
- ↑ Williams-Frame A, Carpenter JS (2009). “Costs of hormonal and nonhormonal prescription medications for hot flashes”. Womens Health (Lond). 5 (5): 497–502. doi:10.2217/whe.09.49. PMC 3637932. PMID 19702449.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Rahmah Al-Edresi, M.D.[2]